INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 387 filers reported holding INSMED INC in Q2 2024. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,829 | – | 341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 955,462 | $24,460,000 | 13.75% |
| Foresite Capital Management IV, LLC | 1,561,185 | $39,966,000 | 11.30% |
| Asymmetry Capital Management, L.P. | 730,440 | $18,699,000 | 10.13% |
| NEXTHERA CAPITAL LP | 470,741 | $12,051,000 | 10.04% |
| Palo Alto Investors LP | 7,890,917 | $202,007,000 | 9.82% |
| Vivo Capital, LLC | 1,748,174 | $44,753,000 | 4.19% |
| ACUTA CAPITAL PARTNERS, LLC | 435,500 | $11,149,000 | 3.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $9,111,000 | 3.38% |
| Consonance Capital Management LP | 1,711,150 | $43,805,000 | 3.10% |
| Opus Point Partners Management, LLC | 26,936 | $690,000 | 1.02% |